←
Rachel Ann Connor3,719 posts
Rachel Ann Connor avatar

Rachel Ann Connor

@coracle1

Director of Research Partnerships, BreakthroughT1D UK. Lover of science, data, and the power of words. Tea-drinking, cake-scoffing mum-of-two. All views my own.

◷ Joined March 2009▧ 479 Photos and videos
elsadiabetes avatar
⟳ Rachel Ann Connor retweeted
elsadiabetes@elsadiabetes·May 14

T1D develops before you have any symptoms. Thanks to years of dedicated research we now know that people can start developing T1D for more than 15 years before symptoms show. The development of the condition can be split into separate stages. breakthrought1d.org.uk/knowl…

Post attachment
Prof May Ng OBE 吳 诗 梅 avatar
⟳ Rachel Ann Connor retweeted
Prof May Ng OBE 吳 诗 梅@mayng888·Apr 27

2/3 But some of the most meaningful outputs have been the resources co-created and co-developed with people with lived experience, including infographics, videos, animation and leaflets for clinics for families and HCPs.

Post attachmentPost attachmentPost attachmentPost attachment
Breakthrough T1D UK avatar
⟳ Rachel Ann Connor retweeted
Breakthrough T1D UK@BT1DUK·Apr 23

The UK Professional Conference on Eating Disorders and Diabetes (UKPCEDD) returns on 8 June 2026 at The Slate, University of Warwick. The conference brings together leading professionals, researchers, and experts to explore the critical intersection between eating disorders and diabetes, offering research updates and best practices for patient care. Don’t miss out, early bird ticket sales end on 30 April! Find out more: bit.ly/4enHChB #T1DE #T1D #GBdoc

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

I’ve managed to miss taking useful photos from Mike Weiss’s talk about his work on a novel insulin-glucagon fusion protein! Exciting to see the progress the team is making and the prospect of a company to develop this idea! Watch this space!

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

Questions both comment how clear it is that this work is so relevant to thinking about early #T1D in the clinic. Teifion describes how this data indicates that the window of opportunity to protect beta cells in the youngest kids is small, underlining the importance of screening

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

As the pancreas develops there is a big shift from lots of little clusters of insulin producing/endocrine cells to fewer much larger groups (classic islets) is so striking!

Post attachment
Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

Over to the @ibex01 team, with Teifion Luckett presenting on behalf of @SarahIBEx. This project focusses on understanding how and why #T1D development looks so different between different people: especially between the youngest people with T1D and people diagnosed as adults

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

…so Vicky describes finding molecular engineering approaches to move from a microencapsulation approach to a nano-encapsulation approach, which should allow a more responsive behaviour from the islets inside the coating

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

Vicky talks about the process she and the team have been through in optimising their microencapsulation approach, providing protective ‘bubbles’ around manufactured islets…. But it might not be quite as good a coating as wanted to really mange glucose well…

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

Vicky also sets out the case for generating GMP-grade transplantable cells in the UK and Europe and gives a tantalising view of the innovative work of @IldemAkerman in Birmingham who collaborates on this project

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

Next up is Professor Vicky Salem, who shifts focus to cell replacement therapy. Vicky sets the context for cell therapy with an explanation of the current amazing innovations in cell therapy for #T1D, but also the limitations that exist with these approaches #dukpc

Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

The spatial transcriptomics with that the team have been working on is beautiful, and provides incredible insight into how beta cells develop in the earliest stages of pancreas development: I could happily spend a lot longer looking at this wonderful data!

Post attachment
Rachel Ann Connor avatar
Rachel Ann Connor@coracle1·Apr 23

@JamesCantleyLab takes the stage first, describing the painstaking work developing an assay platform to screen for drugs to kick start growth of new beta cells. James drives home the fierce complexity of drug discovery & the importance of his fellowship to enable this work #dukpc